Canada markets open in 9 hours 5 minutes

Canntab Therapeutics Limited (PILL.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.7300-0.0100 (-1.35%)
At close: 1:29PM EDT
Currency in CAD

Valuation Measures

Market Cap (intraday) 522.97M
Enterprise Value 319.58M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)172.28
Price/Book (mrq)5.84
Enterprise Value/Revenue 3146.85
Enterprise Value/EBITDA 6-9.10

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 351.02%
S&P500 52-Week Change 315.51%
52 Week High 31.1500
52 Week Low 30.0000
50-Day Moving Average 30.6559
200-Day Moving Average 30.7040

Share Statistics

Avg Vol (3 month) 331.38k
Avg Vol (10 day) 327.11k
Shares Outstanding 531.47M
Float 28.02M
% Held by Insiders 111.84%
% Held by Institutions 10.00%
Shares Short (Aug. 13, 2020) 43.45k
Short Ratio (Aug. 13, 2020) 40.09
Short % of Float (Aug. 13, 2020) 4N/A
Short % of Shares Outstanding (Aug. 13, 2020) 40.01%
Shares Short (prior month Jul. 14, 2020) 44.4k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Mar. 07, 2016
Last Split Factor 21:200
Last Split Date 3Apr. 19, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends May 30, 2020
Most Recent Quarter (mrq)May 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)-1,835.39%

Management Effectiveness

Return on Assets (ttm)-37.75%
Return on Equity (ttm)-89.96%

Income Statement

Revenue (ttm)133.33k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-100.00%
Gross Profit (ttm)124.78k
Net Income Avi to Common (ttm)-2.61M
Diluted EPS (ttm)-0.1000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.09M
Total Cash Per Share (mrq)0.07
Total Debt (mrq)726.42k
Total Debt/Equity (mrq)20.59
Current Ratio (mrq)2.46
Book Value Per Share (mrq)0.12

Cash Flow Statement

Operating Cash Flow (ttm)-1.9M
Levered Free Cash Flow (ttm)-1.77M